“…It was also not possible to define fully how neoadjuvant radiotherapy influenced thrombus viability or to separate these patients from the series where they were reported, which made exclusion of these studies from the sensitivity analysis necessary. Resection margins were not often discussed, and it remains unclear whether incomplete thrombectomy increases the risk of disease relapse 1 , 2 , 14 , 15 , 24 , 43 , 51 . Adjuvant radiotherapy was usually given in these situations as mandated by tumour-staging protocols, but postoperative chemotherapy, relapse and mortality outcomes were often generalized, and it was difficult to define fully relationships between these and thrombus response and viability.…”